Henry Schein, Inc. (NASDAQ:HSIC) Receives Average Recommendation of “Moderate Buy” from Brokerages

Shares of Henry Schein, Inc. (NASDAQ:HSIC) have earned a consensus recommendation of “Moderate Buy” from the eleven analysts that are presently covering the firm, Marketbeat.com reports. Five investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating on the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $81.10.

Several equities analysts have recently commented on the stock. Barrington Research reissued an “outperform” rating and issued a $90.00 target price on shares of Henry Schein in a report on Wednesday, February 26th. Mizuho assumed coverage on shares of Henry Schein in a report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price on the stock. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Wells Fargo & Company started coverage on shares of Henry Schein in a report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 target price on the stock. Finally, Jefferies Financial Group boosted their price target on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of HSIC. Palestra Capital Management LLC bought a new position in Henry Schein during the fourth quarter valued at $182,988,000. Lyrical Asset Management LP bought a new position in Henry Schein during the fourth quarter valued at $126,655,000. Norges Bank bought a new position in Henry Schein during the fourth quarter valued at $103,301,000. Steadfast Capital Management LP increased its position in Henry Schein by 254.2% during the fourth quarter. Steadfast Capital Management LP now owns 1,637,808 shares of the company’s stock valued at $113,336,000 after acquiring an additional 1,175,408 shares during the last quarter. Finally, ING Groep NV bought a new position in Henry Schein during the third quarter valued at $63,226,000. Institutional investors own 96.62% of the company’s stock.

Henry Schein Price Performance

Shares of NASDAQ:HSIC opened at $72.96 on Friday. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein has a 1-year low of $63.67 and a 1-year high of $82.49. The company has a market capitalization of $9.06 billion, a P/E ratio of 30.02, a P/E/G ratio of 2.13 and a beta of 0.91. The firm’s 50 day simple moving average is $74.44 and its two-hundred day simple moving average is $72.51.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company had revenue of $3.19 billion during the quarter, compared to analysts’ expectations of $3.25 billion. During the same period last year, the firm posted $0.66 EPS. Henry Schein’s quarterly revenue was up 5.8% compared to the same quarter last year. Research analysts expect that Henry Schein will post 4.74 EPS for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.